![Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology | Anais Brasileiros de Dermatologia Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology | Anais Brasileiros de Dermatologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//03650596/00000095000000S1/v2_202012310755/S0365059620302336/v2_202012310755/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/eUng1vrpKblV+WbjTtysIq0cwxxjaMYv06TlJpDL+pRsYz0vh/hSBOXGOR6xAWzdiyDez6djx8rFjjXChbKR9vUn/OFZa7Naiy1wX36Wziq8zonN8jeCl4MeUaydOMBXrS0mL2Vd3E9OiPUK5TuKWDc5XwwUqlrsir6wVGIVY5GSJkEv4OXWZsGbNRJX5kIQtdoEqmx5WKhEVeeUFDt7WxVrt7sPIbmpWspLi4bRVDxzn6iMeoNJfgXTE33bBYhuc4Di8knzvvDkyj7drJfZtyuMk/4pI6CZVVYY6KPW/r)
Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology | Anais Brasileiros de Dermatologia
![Frontiers | Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data Frontiers | Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data](https://www.frontiersin.org/files/MyHome%20Article%20Library/733526/733526_Thumb_400.jpg)
Frontiers | Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
![Patient demographics, dose, daily dose/kg, duration of treatment and... | Download Scientific Diagram Patient demographics, dose, daily dose/kg, duration of treatment and... | Download Scientific Diagram](https://www.researchgate.net/profile/Marius-Rademaker/publication/282913041/figure/tbl2/AS:895191053512704@1590441587443/Patient-demographics-dose-daily-dose-kg-duration-of-treatment-and-cumulative-dose-in_Q320.jpg)
Patient demographics, dose, daily dose/kg, duration of treatment and... | Download Scientific Diagram
![Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/isochart2.jpg)
Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand
![Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants | HTML Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants | HTML](https://www.medicaljournals.se/acta/html-editor/html-img/5644/5644_22741.png)
Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants | HTML
![Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/isochart.jpg)
Prescribing isotretinoin for patients with acne in primary care - Best Practice Advocacy Centre New Zealand
![Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2011/77/6/Images/ijdvl_2011_77_6_688_86482_t3.jpg)
Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial - Indian Journal of Dermatology, Venereology and Leprology
![The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3970835/bin/jcad_7_2_suppl-g002.jpg)
The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC
![A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris. - Abstract - Europe PMC A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5038098/bin/IDOJ-7-378-g005.jpg)
A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris. - Abstract - Europe PMC
![The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3970835/bin/jcad_7_2_suppl-g004.jpg)
The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. - Abstract - Europe PMC
![Isotretinoin use for acne in obese and overweight young people: A retrospective study - Journal of the American Academy of Dermatology Isotretinoin use for acne in obese and overweight young people: A retrospective study - Journal of the American Academy of Dermatology](https://www.jaad.org/cms/asset/4bac32fb-2823-4be6-b218-b3fc0147709e/fx1.jpg)
Isotretinoin use for acne in obese and overweight young people: A retrospective study - Journal of the American Academy of Dermatology
![Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review - JAAD International Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review - JAAD International](https://www.jaadinternational.org/cms/asset/8cbcafa3-00cb-4b53-8125-9c27b037ce9f/gr1.jpg)
Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review - JAAD International
![Acne clearance by number of courses of isotretinoin in patients treated... | Download Scientific Diagram Acne clearance by number of courses of isotretinoin in patients treated... | Download Scientific Diagram](https://www.researchgate.net/profile/Marius-Rademaker/publication/282913041/figure/tbl5/AS:895191053508610@1590441587529/Acne-clearance-by-number-of-courses-of-isotretinoin-in-patients-treated-for-acne-vulgaris_Q320.jpg)
Acne clearance by number of courses of isotretinoin in patients treated... | Download Scientific Diagram
![Frontiers | Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data Frontiers | Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data](https://www.frontiersin.org/files/Articles/733526/fphar-12-733526-HTML/image_m/fphar-12-733526-t001.jpg)